Dr. Yasaman Kianirad, MD

Dr. Kianirad practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Kianirad's NPI, 1568759975, was assigned on July 6, 2011. Dr. Kianirad holds Illinois license 036-139084.

Dr. Kianirad's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Kianirad's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Kianirad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kianirad practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kianirad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kianirad is licensed in Illinois.

CMS data shows 122 Medicare services from Dr. Kianirad across 4 procedure codes in 2024, all of them office visits, for 101 Medicare patients. Medicare paid $10,822 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Kianirad in 2024. The largest group is 65 to 74, with 39 patients. 71% of them have high blood pressure, and 63% have high cholesterol. 60% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kianirad's median patient age at 68, with 46% women.

In 2024, Dr. Kianirad wrote 786 Medicare Part D claims for 106 patients. 85% of them were for generic drugs. CMS names the drug for 690 of them, across 15 drugs with 11 or more claims each, at $698,004 in total drug cost. In 2023, CMS named 599 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kianirad for performance year 2024, reported as part of a group. Dr. Kianirad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Kianirad, published from 2017 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Parkinson Disease. Dr. Kianirad's most frequent co-authors are Jonathan Bundy, MD, Tarek A. Hijaz, MD and Christopher Sami Oustwani, MD.

CMS Open Payments shows 46 general payments to Dr. Kianirad from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Abbott Laboratories paid the most, $1,422.